Jubilant Biosys appoints Venugopala Reddy Pagadala as VP & CFO, CRDMO

Published On 2025-07-09 11:00 GMT   |   Update On 2025-07-09 11:00 GMT
Advertisement

Noida: Jubilant Biosys Limited, a subsidiary of Jubilant Pharmovahas announced the appointment of Venugopala Reddy Pagadala as VP & CFO, CRDMO.

"We are happy to announce & welcome Mr Venugopala Reddy Pagadala, who has joined us as VP & CFO, CRDMO. We extend a warm welcome to Mr. Venugopala and are excited about the expertise and insights he will bring to our organization. We wish him tremendous success in his new role and look forward to achieving great milestones together," 
Jubilant stated in a LinkedIn post.
He will be responsible for leading the Finance function across all segments, sites, and businesses of the company's CRDMO business.
Venugopala joins Jubilant from Dr Reddy’s, where the last role he held was that of Cluster Finance Head – CTOs (API). In this role, he headed finance for 8 API Manufacturing Units located in India, Mexico, and UK. Prior to Dr Reddy's he also worked at 
Syngene International Limited, Cipla, 
Nestle India, and Bharat Petroleum Corporation Limited.

Jubilant Biosys Ltd (JBL) offers end-to-end CRDMO solutions in Structural Biology, Computational Chemistry, Medicinal & Synthetic Chemistry, in-vitro and in-vivo Biology, DMPK, Toxicology, Process R&D & Manufacturing to various Biotech & Pharma companies pursuing drug discovery, development and manufacturing. Jubilant Biosys Limited (JBL) is a subsidiary of Jubilant Pharmova, serving the global life sciences, agrochemicals and specialty chemicals industry through its research centers & manufacturing facilities in India. Jubilant’s services in discovery research include;

Jubilant’s services in discovery research includes;

• Target Identification/Target Validation to Lead Optimization/ Preclinical candidate, for multiple therapeutic areas viz; Oncology, Metabolic Disorders, CNS, Pain and Inflammation.

• Functional services comprising of computational chemistry/ molecular modeling, medicinal chemistry, synthetic chemistry, scale-up (Non-GMP & GMP), structural biology, ADME-PK,in-vitro and in-vivo biology and IND enabling GLP toxicology.

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News